TEMPO.CO, Jakarta – Pyridam Farma (PYFA) together with AIDOT Inc. will soon release the Cerviray AI healthcare product. This tool is a portable cervical cancer detection tool that can help women in early detection cervical cancer with a sensitivity level of 93 percent and a specificity level of 89 percent.
Cerviray AI’s Artificial Intelligence (AI) software uses an image of a patient’s cervix captured by the device to automatically indicate the possible severity or status of the disease. The results that have been analyzed by the AI server are immediately sent to experts as additional data to make the necessary diagnosis more accurately. Cerviray AI is produced by an Artificial Intelligence (AI) company in the health sector from South Korea, namely AIDOT Inc.
Cerviray AI is equipped with an LED (anti-glare function), a zoom feature of up to 3-5 times optical and a focus level that can be adjusted automatically or manually. This can help the process of taking pictures of the cervix or cervix carried out by experts to be faster, clearer and more accurate.
Director of Pyridam Farma Widjanarko Brotosaputro said Pyridam Farma wanted to participate in supporting government programs in an effort to increase awareness of Indonesian women on cervical health. The lack of awareness of Indonesian women to carry out the Human Papilloma Virus (HPV) vaccine and routine self-examination is one of the causes of the high mortality caused by cervical cancer. “Therefore, Pyridam Farma believes that the presence of Cerviray AI can help women to start getting themselves checked so that they are protected from the dangers of cervical cancer,” he said in a press statement received by Tempo on July 16, 2022.
Obgyn DoctorGeossefi Purnawarman as the Director and one of the owners of the Medika Dramaga Hospital Bogor said the use of artificial intelligence (AI) technology in the medical world is very useful because it can make the examination process easier, more efficient and effective and can be well documented. “In addition, by using AI technology, patients will not only get verbal explanations and education from doctors but also virtually so that patients better understand the condition of their bodies recording,” he said.
Cerviray AI has received various certifications and patents for medical devices from various countries, and the effectiveness of this Cerviray AI device has been tested by Korea University Anam Hospital and Seoul National University Bundang Hospital. With AIDOT’s commitment to help women around the world, AIDOT is present in Indonesia through Pyridam Farma.
Pyridam Farma hopes that the technological innovation presented by Cerviray AI can be an answer for experts as well as an option for Indonesian women in routine cervical examinations that provide faster and more accurate results.
Baca: Prevent Cervical Cancer, This is the Recommended Age for HPV Vaccination
–
